Clinical Research Directory
Browse clinical research sites, groups, and studies.
18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer
Sponsor: Hunan Cancer Hospital
Summary
This study uses FES PET/CT imaging to evaluate estrogen receptor-positive breast cancer. FES PET/CT is a type of imaging that can show whether breast cancer cells have estrogen receptors. The purpose of this study is to see how well FES PET/CT can help doctors: (1) diagnose ER-positive breast cancer, (2) plan the best treatment, and (3) check how well treatment is working. Participants will undergo FES PET/CT scans as part of their regular cancer care or study procedures. The results may help improve how doctors use imaging to guide treatment decisions for patients with ER-positive breast cancer.
Official title: 18F-FES PET/CT in the Diagnosis, Treatment Planning, and Response Assessment of ER-Positive Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2024-05-09
Completion Date
2028-12-31
Last Updated
2026-10-05
Healthy Volunteers
No
Conditions
Locations (1)
Hunan Cancer Hospital
Changsha, Hunan, China